First-in-human trial exploring safety, antitumor activity, and pharmacokinetics of Sym013, a recombinant pan-HER antibody mixture, in advanced epithelial malignancies von Berlin, Jordan, Tolcher, Anthony W., Ding, Cliff, Whisenant, Jennifer G., Horak, Ivan D., Wood, Debra L., Nadler, Paul I., Hansen, Ulla Holm, Lantto, Johan, Skartved, Niels Jørgen Ø., Pedersen, Mikkel W., Patnaik, Amita

Volltext

Directed evolution of gene-shuffled IFN-α molecules with activity profiles tailored for treatment of chronic viral diseases von Brideau-Andersen, Amy D, Huang, Xiaojian, Sun, Siu-Chi Chang, Chen, Teddy T, Stark, Diane, Sas, Ian J, Zadik, Linda, Dawes, Glenn N, Guptill, Douglas R, McCord, Robert, Govindarajan, Sridhar, Roy, Ajoy, Yang, Shumin, Gao, Judy, Chen, Yong Hong, Skartved, Niels Jørgen Ø, Pedersen, Annette K, Lin, David, Locher, Christopher P, Rebbapragada, Indrani, Jensen, Anne Dam, Bass, Steven H, Nissen, Torben L. Straight, Viswanathan, Sridhar, Foster, Graham R, Symons, Julian A, Patten, Phillip A

Volltext

Rozrolimupab, a mixture of 25 recombinant human monoclonal RhD antibodies, in the treatment of primary immune thrombocytopenia von Robak, Tadeusz, Windyga, Jerzy, Trelinski, Jacek, von Depka Prondzinski, Mario, Giagounidis, Aristoteles, Doyen, Chantal, Janssens, Ann, Álvarez-Román, María Teresa, Jarque, Isidro, Loscertales, Javier, Rus, Gloria Pérez, Hellmann, Andrzej, Jêdrzejczak, Wiesław Wiktor, Kuliczkowski, Kazimierz, Golubovic, Lana M., Celeketic, Dusica, Cucuianu, Andrei, Gheorghita, Emanuil, Lazaroiu, Mihaela, Shpilberg, Ofer, Attias, Dina, Karyagina, Elena, Svetlana, Kalinina, Vilchevska, Kateryna, Cooper, Nichola, Talks, Kate, Prabhu, Mukhyaprana, Sripada, Prasad, Bharadwaj, T.P.R., Næsted, Henrik, Skartved, Niels J.Ø., Frandsen, Torben P., Flensburg, Mimi F., Andersen, Peter S., Petersen, Jørgen

Volltext